Efficient Hydrolysis of Dichlorvos in Water by <i>Stenotrophomonas acidaminiphila</i> G1 and Methyl Parathion Hydrolase. [PDF]
Mei Q, Hua R.
europepmc +1 more source
Vinpocetine-An "Old" Drug with a New Face: Moving Toward a Better Understanding of Its Neuroprotective Mechanism of Action. [PDF]
Vizi ES, Kiss B.
europepmc +1 more source
Adjuvant Cilostazol Therapy to Help Restore Atrioventricular Conduction in Lyme Carditis. [PDF]
Aryal B, Mandal P, Meyer MF.
europepmc +1 more source
RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma. [PDF]
And Mathematical Methods In Medicine C.
europepmc +1 more source
Intraprocedural Management of Pulmonary Embolism Patients Undergoing Transcatheter Treatment, and Ventilatory and Cardiac Support. [PDF]
Sławek-Szmyt S, Araszkiewicz A.
europepmc +1 more source
Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype. [PDF]
Forbes LM, Cornwell WK.
europepmc +1 more source
Related searches:
Phosphodiesterase in Psoriasis
British Journal of Dermatology, 1969SUMMARY. . Phosphodiesterase activity was determined by a fluorometric method using thymidine-5′-3–0-methoxy fluorescein phosphate as a substrate, in blood serum, finger-blood, normal skin, foreskin and psoriatic skin. Higher enzyme activity was found in psoriasis both in blood-serum and finger-blood in comparison with normal controls ...
F, Zaruba, M A, Karasek, E M, Farber
openaire +2 more sources
Phosphodiesterase 4 inhibitors
Journal of the American Academy of Dermatology, 2018Historically, drugs available for treating atopic dermatitis (AD) have been limited to topical corticosteroids and topical calcineurin inhibitors, with systemic immunosuppressants and phototherapy reserved for severe AD. Despite their efficacy and infrequent adverse events, phobia about the use of topical steroids and calcineurin inhibitors has limited
Rema, Zebda, Amy S, Paller
openaire +2 more sources
Phosphodiesterase-5 Inhibitors
2013Nitric oxide (NO) signaling plays a key role in modulating vascular tone and remodeling in the pulmonary circulation. The guanylate cyclase/cyclic guanylate monophosphate-signaling pathway primarily mediates nitric oxide signaling. This pathway is critical in normal regulation of the pulmonary vasculature, and is an important target for therapy in ...
Barbara A, Cockrill, Aaron B, Waxman
openaire +2 more sources

